Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Vishal Malkan of malkansview.com is of the view that one may buy Biocon with a target of Rs 910.
According to Jay Thakkar of Sharekhan, one may sell ONGC with a target of Rs 258.10.
Jay Thakkar of Sharekhan advises buying Ceat with a target of Rs 1341.
Gaurav Bissa of LKP Securities is of the view that one can buy Hexaware Tech and Cairn India.
Sumeet Jain of Destimoney Securities is of the view that one may buy Hexaware Technologies with a target of Rs 211.50.
Ashwani Gujral of ashwanigujral.com is of the view that one can look at Biocon while Ajanta Pharma can give 25-30 percent return.
Rakesh Bansal of RK Global is of the view that one may sell Biocon with a target of Rs 832.
In an interview to CNBC-TV18, Deven Choksey, MD of KRChoksey Investment Managers Private Limited shared his readings and outlook on specific stocks and sectors.
Citi maintains buy call Biocon as it makes regulatory filing of Gargine in Europe. It says the Biocon is most leveraged play on global biosimilars opportunity.
Rahul Shah of Motilal Oswal recommends going long in IndusInd Bank and advises shorting Biocon.
According to Amit Gupta of ICICIdirect, one can buy Castrol India and short LIC Housing Finance and Biocon.
Sanjiv Bhasin of IIFL is of the view that Dr Reddy's Labs is the top pick on decline along with Cipla.
Prakash Gaba of prakashgaba.com is of the view that Gati can climb to Rs 145 while Biocon can slip to Rs 920.
Rahul Shah of Motilal Oswal is of the view that one can buy Jain Irrigation and ICICI Bank and short Biocon.
According to Hemant Thukral of Aditya Birla Money, one can buy Biocon and Power Finance Corporation.
Morgan Stanley is underweight on Wipro with target price at Rs 460 per share stating that growth is weakest among large peers that may keep valuation low.
Sameet Chavan of Angel Broking is of the view that one may buy Karur Vysya Bank with a target of Rs 534.
Ashwani Gujral of ashwanigujral.com recommends buying Biocon, Tata Chemicals and Escorts.
In an interview to CNBC-TV18, Deven Choksey of KRChoksey Investment Managers shared his reading and outlook on the market and specific stocks.
In an interview with CNBC-TV18, SP Tulsian of sptulsian.com listed his stock picks and market outlook.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy United Spirits and Biocon and sell CESC.
Rahul Shah of Motilal Oswal advises buying Bharat Forge, DHFL and Biocon.
Rajat Bose of rajatkbose.com is of the view that one can prefer pharma stocks.
Hemant Thukral of Aditya Birla Money is of the view that one can sell Bajaj Auto and buy Biocon.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Biocon, Tata Chemicals and financial stocks and advises selling Mindtree.